The same business leaders who are publicly cordial to Donald Trump—even to his face—privately bemoan the havoc the ...

AM showers, high wind, blowing dust, fire danger and cooler on this Tuesday. Ukrainian government sells T-shirts with viral ...

From epic fails to the cutest reactions, these cats know how to entertain! Watch them jump, slip, and surprise themselves in ...

Since the pandemic, banks in the U.S., have stepped back, making room for private lenders, who don't take customer deposits.

We didn't know how good we had it with "Harold and the Purple Crayon." In a perfect vacuum, I suppose it would be possible to watch “The Unbreakable Boy” as a benign — if uncommonly basic ...

The currently available Pfizer JN.1 vaccine provides a reasonable match with ... The report, "I Didn't Want to Smile", calls for universal, free, Te Tiriti o Waitangi-consistent dental. Golden Shears ...

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. The New York pharma is ending global development and commercialization of ...

However, when Trump introduced some of the dignitaries in attendance, Pfizer chief Albert Boula was not well received. 'We also have the head of Pfizer here so I want to thank him, one of the ...

Pfizer generated strong growth last year despite a significant drop in COVID revenue. The company's business is solid, and its growth prospects are encouraging. Investors, however, remain ...

Pfizer hopes a unique life-extension benefit for its Talzenna can serve to further expand the drug’s already broadest-in-class U.S. label in prostate cancer. Following an FDA approval in 2023 ...

Pfizer stock has suffered as demand for the company’s top selling coronavirus products declined. The pharma giant has reached an important transition point. Right now, as an investor, you may be ...